Published in Am J Kidney Dis on July 23, 2009
Nutritional vitamin D supplementation and health-related outcomes in hemodialysis patients: a protocol for a systematic review and meta-analysis. Syst Rev (2015) 1.38
Anaemia management and mortality risk in chronic kidney disease. Nat Rev Nephrol (2013) 1.06
Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol (2011) 0.95
Haemodialysis in an emerging centre in a developing country: a two year review and predictors of mortality. BMC Nephrol (2011) 0.94
Patient care staffing levels and facility characteristics in U.S. hemodialysis facilities. Am J Kidney Dis (2013) 0.88
Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls. Am J Kidney Dis (2010) 0.82
Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients. Kidney Int (2011) 0.78
Erythropoietin bundling: innovative remuneration or the dawn of EPO-profiling? Semin Dial (2010) 0.75
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients. PLoS One (2013) 0.75
Continuous quality improvement in daily clinical practice: a proof of concept study. PLoS One (2014) 0.75
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst (2009) 3.77
Comparison of multi-subject ICA methods for analysis of fMRI data. Hum Brain Mapp (2010) 3.64
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol (2008) 2.72
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med (2012) 2.69
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol (2007) 2.62
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol (2003) 2.23
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol (2010) 1.81
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis (2009) 1.79
Factors related to genital tract trauma in normal spontaneous vaginal births. Birth (2006) 1.74
Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int (2009) 1.72
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int (2004) 1.71
Pure red cell aplasia due to follow-on epoetin. Kidney Int (2008) 1.69
Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol (2004) 1.69
Fournier gangrene: role of imaging. Radiographics (2008) 1.68
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol (2006) 1.61
Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls. Cancer (2004) 1.60
Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis (2002) 1.56
Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis (2007) 1.53
Midwifery care measures in the second stage of labor and reduction of genital tract trauma at birth: a randomized trial. J Midwifery Womens Health (2005) 1.49
Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell (2008) 1.48
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer (2012) 1.47
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant (2004) 1.46
Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis (2003) 1.45
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis (2006) 1.45
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer (2003) 1.44
Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis (2004) 1.44
Alcohol and sexual risk behavior among migrant female sex workers and male workers in districts with high in-migration from four high HIV prevalence states in India. AIDS Behav (2010) 1.43
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int (2008) 1.43
Acute coronary syndrome in ESRD patients. Kidney Int (2008) 1.43
Hospital admissions in elderly patients on chronic hemodialysis. Int Urol Nephrol (2011) 1.41
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun (2007) 1.37
Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev (2003) 1.37
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int (2008) 1.34
A validation study of the Canadian Organ Replacement Register. Clin J Am Soc Nephrol (2011) 1.34
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant (2009) 1.33
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30
Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis (2005) 1.29
Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci (2008) 1.29
Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27
Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis (2004) 1.27
Disclosure of the HIV infection status in children. Indian J Pediatr (2009) 1.27
A conserved signal and GTPase complex are required for the ciliary transport of polycystin-1. Mol Biol Cell (2011) 1.25
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2011) 1.25
Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol (2003) 1.25
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J (2005) 1.25
Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol (2006) 1.23
Racial differences in health-related quality of life among hemodialysis patients. Kidney Int (2004) 1.22
Association between cancer-free survival and telomere DNA content in prostate tumors. J Urol (2005) 1.21
Aerosol chemistry over a high altitude station at northeastern Himalayas, India. PLoS One (2010) 1.19
Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol (2009) 1.17
Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol (2007) 1.15
Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project. J Am Soc Nephrol (2003) 1.14
Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment. Int Urol Nephrol (2008) 1.14
A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease. Am J Kidney Dis (2002) 1.14
Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.13
Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.13
The empirical basis for determinations of medical futility. J Gen Intern Med (2010) 1.13
Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.11
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis (2005) 1.11
The Zuni kidney project: a collaborative approach to an epidemic of kidney disease. J Am Soc Nephrol (2003) 1.10
Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol (2013) 1.10
Imperial or empirical measures of dialysis quality? Am J Kidney Dis (2007) 1.09
Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant (2013) 1.09
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J Virol (2002) 1.08
A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev (2013) 1.08
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol (2011) 1.07
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. Pharmacotherapy (2007) 1.06
Polymer thin films embedded with metal nanoparticles for electrochemical biosensors applications. Biosens Bioelectron (2012) 1.06
The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc (2008) 1.05